key: cord-0030679-nzp0wajq
authors: Pansini, Antonella; Lombardi, Angela; Morgante, Maria; Frullone, Salvatore; Marro, Anna; Rizzo, Mario; Martinelli, Giuseppe; Boccalone, Eugenio; De Luca, Antonio; Santulli, Gaetano; Mone, Pasquale
title: Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults
date: 2022-04-14
journal: Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2022.831556
sha: 3669b2bd036e43f3ad95db7d690fa0cbefc6ac58
doc_id: 30679
cord_uid: nzp0wajq

BACKGROUND: Frailty is a multidimensional condition typical of elders. Frail older adults have a high risk of functional decline, hospitalization, and mortality. Hypertension is one of the most common comorbidities in elders. Hyperglycemia (HG) is frequently observed in frail older adults, and represents an independent predictor of worst outcomes, with or without diabetes mellitus (DM). We aimed at investigating the impact of HG on physical impairment in frailty. METHODS: We studied consecutive older adults with frailty and hypertension at the ASL (local health unit of the Italian Ministry of Health) of Avellino, Italy, from March 2021 to September 2021. Exclusion criteria were: age <65 years, no frailty, no hypertension, left ventricular ejection fraction <25%, previous myocardial infarction, previous primary percutaneous coronary intervention and/or coronary artery bypass grafting. Blood glucose, Hb1Ac, and creatinine were measured in all patients. Physical frailty was assessed applying the Fried Criteria; we performed a 5-meter gait speed (5mGS) test in all patients. RESULTS: 149 frail hypertensive older adults were enrolled in the study, of which 82 had normoglycemia (NG), and 67 had HG. We observed a significantly slower 5mGS in the HG group compared to the NG group (0.52 ± 0.1 vs. 0.69 ± 0.06; p<0.001). Moreover, we found a strong and significant correlation between 5mGS and glycemia (r: 0.833; p<0.001). A multivariable linear regression analysis using 5mGS as a dependent variable revealed a significant independent association with glycemia (p<0.001) after adjusting for likely confounders. CONCLUSIONS: HG drives physical impairment in frail hypertensive older adults independently of DM.

Frailty is a multidimensional condition typical of elders that determines physical decline. Frail older adults have a high risk of functional decline, hospitalization, and mortality (1) (2) (3) (4) . Hence, a careful geriatric evaluation is one of the best strategies to obtain an early diagnosis of physical impairment, and managing comorbidities and complications is fundamental to counteract it (5) (6) (7) (8) (9) (10) (11) . Hypertension is one of the most common comorbidities in elders, affecting endothelial function, leading to oxidative stress, inflammation, and atherosclerosis (12) (13) (14) (15) (16) (17) (18) (19) .

Hyperglycemia (HG) is frequently observed in frail hypertensive older adults, and we and others have shown that it represents an independent predictor of worst outcomes, even if diabetes mellitus (DM) is not present (20) (21) (22) (23) . Indeed, HG drives inflammation and oxidative stress, leading to endothelial dysfunction, with a negative impact on frail patients (7, (24) (25) (26) (27) (28) .

In this context, reaching and maintaining an optimal glycemic control may be crucial to reduce the incidence of functional decline and avoid complications (11, (29) (30) (31) (32) . On these grounds, we investigated the impact of HG on physical impairment in frail hypertensive older adults.

We studied consecutive older adults with frailty and hypertension at the ASL (local health unit of the Italian Ministry of Health) of Avellino and Caserta, Italy, from March 2021 to September 2021.

Inclusion criteria were: Age ≥65 years; frailty; primary hypertension. Exclusion criteria were: Age <65 years; absence of frailty; secondary hypertension or absence of hypertension; previous myocardial infarction, left ventricular ejection fraction <25%, and previous cardiac revascularization.

HG was defined as blood glucose level ≥140 mg/dL according to previous investigations that evaluated HG in complex patients, both diabetic and non-diabetic (33) (34) (35) (36) (37) , and following ADA recommendations, which refer to this value for hospitalized patients (38) and/or subjects with impaired glucose tolerance (39) .

Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg on repeated measurements, or as a previously diagnosed hypertension (40) . Blood samples to measure glycemia, HbA1c, hyperlipidemia, and creatinine were taken from all patients. The study was approved by the Campania Nord Ethical Committee. A written informed consent was signed by all patients.

A diagnosis of frailty status was made according to the Fried Criteria, as we previously reported (19, 41) :

-Weight loss (unintentional loss ≥4.5 kg in the past year); -Weakness (handgrip strength in the lowest 20% quintile at baseline, adjusted for sex and body mass index); -Exhaustion (poor endurance and energy, self-reported); Frailty was diagnosed with at least 3 criteria out of 5. A 5-meter gait speed (5mGS) test was performed in all patients, as we previously described (42) . 5mGS was advocated as a reliable measure of physical capacity in frail patients with cardiovascular diseases (43) . Indeed, this test evaluates lower extremity muscle function, neurological and cardiopulmonary capacity (44, 45) .

Data are presented as mean ± SD or percentage. We developed a dispersion model using Pearson analysis to assess the correlation between glycemia and 5mGS. To explore the impact of comorbidities, we carried out a multivariable linear regression model with a 5mGS test as a dependent variable. All calculations were performed using the software Statistical Product and Service Solutions (SPSS) version 26.

We screened 189 frail hypertensive patients. Since 13 patients did not give their consent and 27 subjects did not meet inclusion criteria, 149 patients were enrolled in the study, of which 82 had normoglycemia (NG) and 67 had HG (Figure 1 ).

Patients were similar in age, BMI, sex distribution, and comorbidities ( Table 1) . We found a strong and significant correlation between 5mGS and glycemia (r: 0.833; 95% C.I.: -0.8766 to -0.7765; p<0.001) in all patients (Figure 2 ).

We observed a significantly slower 5mGS in the HG group compared to the NG group (0.52 ± 0.1 vs. 0.69 ± 0.06; p<0.001) (Figure 3) . A multivariable linear regression analysis with 5mGS as a dependent variable ( Table 2 ) confirmed the significant impact of glycemia (p<0.001) and revealed also an association with COPD (p: 0.043).

Our study indicates that frail hypertensive elders with HG have a significantly lower 5mGS compared to NG subjects. It is important to emphasize the fact that these results refer to a frail hypertensive population of older adults, in which physical performance affects functional decline, loss of independence, and cognitive impairment (30, 46) . Glucose levels may increase the risk of frailty in older adults without DM (31) . It is interesting to observe that these findings are independent of a previous diagnosis of DM as well as from HbA1c values. In this scenario, HG drives physical impairment independently of DM and we speculate that glycemic control appears to be the best way to attempt to reverse physical impairment, with or without DM.

Our study does have some limitations. First, the study population is relatively small; second, there is no follow-up. Therefore, further studies are necessary to confirm our results, ideally in large randomized trials. We also reckon that a majority of our study population is represented by women; this finding is in agreement with the REPOSI Study on elderly people (47) . Consistent with our observations, HG is associated with the development of frailty and lower extremity mobility limitations in older women (48, 49) . Furthermore, a previous study had suggested to consider functionally independent women with osteoporosis and arthritis as a different cluster of frailty (50) .

Taken together, our data indicate that HG drives physical impairment in frail and hypertensive older adults independently from DM and HbA1c values.

The original contributions presented in the study are included in the article. Further inquiries can be directed to the corresponding author.

The studies involving human participants were reviewed and approved by the Campania Nord Ethics Committee. The patients/participants provided their written informed consent to participate in this study.

AP, AL, GS, and PM designed the study, contributed to drafting the manuscript, approved its final version, and made the decision to submit and publish the manuscript. MM, MR, GM, ADL, and PM analyzed data, revised the manuscript's intellectual content, and approved the final version. EB, SF, and AM acquired the data, revised the manuscript's intellectual content, and approved the final version. PM is the guarantor of this work and, as such, had full access to all the data in the study and takes full responsibility for the integrity of the data and the accuracy of data analysis. All authors contributed to the article and approved the submitted version. 

Frailty in Elderly People

Frailty as a Predictor of Adverse Outcomes in Hospitalized Older Adults: A Systematic Review and Meta-Analysis

Frailty and Nutrition: From Epidemiological and Clinical Evidence to Potential Mechanisms

Frailty Status Changes Are Associated With Healthcare Utilization and Subsequent Mortality in the Elderly Population

Effect of Physical Exercise on Cognitive Performance in Older Adults With Mild Cognitive Impairment or Dementia: A Systematic Review

The Prevalence of Frailty and Its Associated Factors in an Italian Institutionalized Older Population: Findings From the Cross-Sectional Alvise Cornaro Center Study

Frailty and Risk of Fractures in Patients With Type 2 Diabetes

Effectiveness of a Multimodal Intervention in Functionally Impaired Older People With Type 2 Diabetes Mellitus

L-Arginine Enhances the Effects of Cardiac Rehabilitation on Physical Performance: New Insights for Managing Cardiovascular Patients During the COVID-19 Pandemic

Physical Activity as Moderator of the Association Between APOE and Cognitive Decline in Older Adults: Results From Three Longitudinal Cohort Studies

Nutrition Management in Older Adults With Diabetes: A Review on the Importance of Shifting Prevention Strategies From Metabolic Syndrome to Frailty

Isolated Systolic Hypertension Is Characterized by Increased Aortic Stiffness and Endothelial Dysfunction

G-Protein-Coupled Receptor Kinase 2 and Hypertension: Molecular Insights and Pathophysiological Mechanisms

Incidence of Dementia Over Three Decades in the Framingham Heart Study

Emerging Biomarkers and Screening for Cognitive Frailty

Sortilin Drives Hypertension by Modulating Sphingolipid/Ceramide Homeostasis and by Triggering Oxidative Stress

Investigation of Frailty as a Moderator of the Relationship Between Neuropathology and Dementia in Alzheimer's Disease: A Cross-Sectional Analysis of Data From the Rush Memory and Aging Project

Subtypes of Physical Frailty and Their Long-Term Outcomes: A Longitudinal Cohort Study

Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia

Diabetes in Older Adults

Metabolic Syndrome and Insulin Resistance Are Associated With Frailty in Older Adults: A Prospective Cohort Study

Stress Hyperglycemia and Acute Ischemic Stroke in-Hospital Outcome

Hyperglycemia Drives Stent Restenosis in STEMI Patients

Diabetes and Restenosis

Oxidative Stress, Inflammation, Endothelial Dysfunction and Incidence of Type 2 Diabetes

Frailty and the Endocrine System

Relationship Between Frailty and Mortality, Hospitalization, and Cardiovascular Diseases in Diabetes: A Systematic Review and Meta-Analysis

Glucose Levels and Risk of Frailty

Correlates of Quality of Life in Older Adults With Diabetes: The Diabetes & Aging Study

Tirzepatide Versus Semaglutide Once Weekly in Type 2 Diabetes

Older Adults: Standards of Medical Care in Diabetes-2022

Stress Hyperglycaemia and Increased Risk of Death After Myocardial Infarction in Patients With and Without Diabetes: A Systematic Overview

Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview

Hyperglycemia-Related Mortality in Critically Ill Patients Varies With Admission Diagnosis

Evaluation of Transient Hyperglycemia in Non-Diabetic Patients With Febrile Neutropenia

Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline

Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2022

Classification and Diagnosis of Diabetes

International Society of Hypertension Global Hypertension Practice Guidelines

L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults. Front Cardiovasc Med (2022)

Cognitive Dysfunction Correlates With Physical Impairment in Frail Patients With Acute Myocardial Infarction

Frailty Assessment in the Cardiovascular Care of Older Adults

Gait Speed and Survival in Older Adults

Empagliflozin Improves Cognitive Impairment in Frail Older Adults with Type 2 Diabetes and Heart Failure with Preserved Ejection Fraction

Physical Frailty in Older Adults Is Associated With Metabolic and Atherosclerotic Risk Factors and Cognitive Impairment Independent of Muscle Mass

Gender-Differences in Disease Distribution and Outcome in Hospitalized Elderly: Data From the REPOSI Study

Is Hyperglycemia Associated With Frailty Status in Older Women?

Hyperglycemia and Incidence of Frailty and Lower Extremity Mobility Limitations in Older Women

Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients

Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest